Quick answer
Biostatistics in clinical research means selecting valid endpoints, planning sample size correctly, and matching tests to your study design. When methods align with research questions and assumptions, results become reliable, interpretable, and publication-ready for journals, ethics boards, and evidence-based decision making.
Key takeaways
- Define the primary endpoint and estimand before choosing a statistical test.
- Match the model to the outcome type, study design, repeated measurements, and dependence structure.
- Report effect estimates and confidence intervals alongside p-values.
- Pre-specify missing-data handling, multiplicity control, and sensitivity analyses.
Why Biostatistics Is Foundational
Clinical research depends on transparent, reproducible evidence. Biostatistics translates medical questions into testable hypotheses, identifies measurement strategy, and quantifies uncertainty. Without rigorous design and analysis, even large studies can produce misleading conclusions.
Design Before Analysis
Strong projects define primary outcomes, inclusion criteria, confounders, and effect size targets before data collection. This prevents post-hoc bias and protects inferential validity. Protocol-level decisions should document statistical assumptions and fallback methods for non-normal or incomplete data.
Interpretation and Reporting
Report effect estimates with confidence intervals, clinical context, and model assumptions. Avoid over-reliance on p-values alone. Transparent reporting should include missing-data handling, sensitivity analyses, and practical implications for clinicians and policy stakeholders.
Practical method
Step-by-Step Workflow
- 1
Translate the clinical question
State the population, intervention or exposure, comparator, outcome, and time horizon. Convert these elements into one primary estimand.
- 2
Map the study variables
Classify outcomes and predictors as continuous, binary, ordinal, count, or time-to-event, and identify clustering or repeated observations.
- 3
Write the analysis plan
Specify the primary model, covariates, assumptions, missing-data strategy, subgroup analyses, and sensitivity checks before examining final outcomes.
- 4
Validate and communicate
Run model diagnostics, quantify uncertainty, distinguish clinical from statistical importance, and report enough detail for reproduction.
Worked example
Randomized trial with a continuous endpoint
- Scenario
- A two-arm trial compares 12-week systolic blood pressure while baseline pressure is available for every participant.
- Approach
- Use an intention-to-treat analysis with ANCOVA: model 12-week pressure using treatment group and baseline pressure. Pre-specify how missing follow-up values will be handled and test a reasonable sensitivity analysis.
- Interpretation
- Report the adjusted mean treatment difference with its 95% confidence interval. Discuss whether the interval includes effects that would be clinically important, rather than treating p < 0.05 as the only conclusion.
Common Mistakes to Avoid
- Choosing the test after seeing the result
- Changing the primary endpoint without disclosure
- Ignoring correlated or repeated observations
- Reporting only p-values without effect sizes
Frequently Asked Questions
What is the first statistical step in a clinical study?
Start by defining a primary endpoint and target effect size, then select an analysis model aligned with study design and outcome type.
Why are confidence intervals important?
Confidence intervals communicate estimate precision and likely effect ranges, offering more context than significance testing alone.